The U.S. Food and Drug Administration approved a label change that expands the use of the drug in Wegovy. It was previously approved to treat obesity.
Wegovy, a popular weight-loss drug known for helping Americans lose weight, has just been approved by federal regulators on Friday to be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or obese. The U.S. Food and Drug Administration approved a label change requested by drugmaker Novo Nordisk that expands the use of semaglutide.
Martha Gulati, a cardiologist at Cedars-Sinai Medical Center in Los Angeles, who estimated that nearly 70% of her heart patients could be eligible for treatment.Ozempic, a lower-dose version of Wegovy, was previously approved to cut the risk of severe heart problems in people with that disease, but it typically costs around $1,300.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Wegovy to reduce heart attack and stroke riskBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patientsThe popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.
Read more »
FDA approves Wegovy for cardiovascular diseaseThe FDA on Friday approved Wegovy to lower the risk of cardiovascular death for people who are obese or overweight, a first of its kind classification.
Read more »
FDA Approves First Treatment for Severe FrostbiteThe U.S. Food and Drug Administration (FDA) on Wednesday approved the first treatment for severe frostbite.
Read more »
FDA Approves Drug to Reduce Accidental Food AllergiesThe new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.
Read more »
FDA approves a drug to treat severe food allergies, including milk, eggs and nutsXolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.
Read more »